Skip to main content
Menu
search
0
tick icon

Sphere Bio

May 20-22, 2025

Hamburg, Germany

Book a meeting with our team
SLAS EU 2025 - Join Sphere Bio at Booth 415

We’re proud to be attending SLAS Europe 2025 Conference and Exhibition, which will bring together the European life sciences and laboratory technology community in Hamburg, Germany, from 20-22 May. This year’s program will showcase cutting-edge advancements in drug discovery, laboratory automation, and screening applications, offering a unique opportunity to explore the latest technologies shaping the future of research.

Don’t miss your chance to be part of the conversations shaping the future of life sciences – register today and join us in Hamburg!

POSTER PRESENTATION

news icon
Title: High Throughput Single Cell Analysis, Sorting and Dispensing Using Multi-Laser Picodroplet Technology
Wednesday, May 21, 4:30pm

Poster Session A

Exhibition Hall H, Poster #1136-A
curtis nicholson

Curtis Nicholson
Executive Director – Strategic Accounts
Sphere Bio

Abstract

Antibody therapeutics dominate drug development; however, lengthy workflows and rising costs in their discovery and development present significant challenges.

Sphere Bio’s Cyto-Mine® system leverages picodroplet technology, microfluidics, and imaging to overcome these hurdles in Antibody Discovery (AbD) and Cell Line Development (CLD), accelerating therapeutic development.

Here we introduce the next-generation Cyto-Mine platform, Cyto-Mine Chroma. This advanced microfluidic platform, equipped with multi-laser, single-cell analysis capabilities, enables high-throughput, multiplex functional screening of millions of cells in a single day. Our findings demonstrate that Cyto-Mine Chroma can precisely sort and dispense cells based on fluorescence signals and sequential gating.

Additionally, it achieves over 90% accuracy in isolating cells based on productivity and membrane dye from mixed populations. In an experiment simulating an AbD workflow, Cyto-Mine Chroma successfully isolated rare cells secreting antigen-specific antibodies with high precision. Furthermore, by utilizing a viability dye alongside IgG-specific probes, we demonstrated its ability to isolate CHO cells producing human IgG4 based on both productivity and viability, without compromising cell performance.

These results highlight Cyto-Mine Chroma’s robust multiplexing capabilities, making it an invaluable tool for isolating specific cell populations in both CLD and AbD workflows.

Visit the event website to register now

REGISTER NOW
news icon

Stay ahead with Sphere Bio

Join our community of forward-thinking scientists and stay informed with the latest breakthroughs, product launches, and exclusive offers. By subscribing to our newsletter, you'll be the first to know about innovations that can transform your lab.